BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

RegeneRx Biopharmaceuticals, Inc. 

3 Bethesda Metro Center, Suite 630

Bethesda  Maryland  20814  U.S.A.
Phone: 301-280-1992 Fax: 301-280-1996


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives $1.35 Million Pursuant To Product License And Stock Purchase Agreement 3/31/2014 8:36:57 AM    More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) And Digital Aria Sign Product License And Stock Purchase Agreements 3/7/2014 8:40:12 AM    More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent For Treatment Of Dry Eye Syndrome 2/24/2014 9:11:42 AM    More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice Of Allowance From U.S. Patent Office For Treatment And Prevention Of Neuro And Muscular Degenerative Diseases 1/16/2014 8:49:08 AM    More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Orphan Drug Designation For Tß4 In The Treatment Of Neurotrophic Keratopathy 1/3/2014 8:58:59 AM    More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice Of Allowance From Canadian Patent Office For Reversal Of Skin Aging 12/20/2013 10:20:12 AM    More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) Releases Results of Phase 2 Clinical Trial on Patients With Epidermolysis Bullosa 6/24/2013 9:30:14 AM    More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) Issues Letter to Sharholders 5/14/2013 10:03:11 AM    More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice of Allowance From Chinese Patent Office for Treatment and Prevention of Heart Disease 2/8/2013 9:42:40 AM    More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice of Allowance From U.S. Patent Office for New Ophthalmic Indications 11/5/2012 9:43:51 AM    More...
12345678910...